Immunoprecise Antibodies Ltd
XTSX:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
XTSX:IPA
Watchlist
Price: 6.5 CAD 0.78% Market Closed
Market Cap: 161.4m CAD

Wall Street
Price Targets

IPA Price Targets Summary
Immunoprecise Antibodies Ltd

There are no price targets for IPA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Immunoprecise Antibodies Ltd Competitors:
Price Targets
603108
Shanghai Runda Medical Technology Co Ltd
57% Upside
A
Agilent Technologies Inc
24% Upside
INNOVACAP
Innova Captab Ltd
20% Upside
SHC
Sotera Health Co
13% Upside
237690
ST Pharm Co Ltd
0% Downside
NANOFH
Nanoform Finland Oyj
159% Upside
LAB
Standard BioTools Inc
5% Downside
CSBR
Champions Oncology Inc
70% Upside

Revenue
Forecast

Revenue Estimate
Immunoprecise Antibodies Ltd

For the last 2 years the compound annual growth rate for Immunoprecise Antibodies Ltd's revenue is 28%.

28%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
39%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Immunoprecise Antibodies Ltd

Operating Income forecast
is not available for
Immunoprecise Antibodies Ltd

Net Income
Forecast

Net Income Estimate
Immunoprecise Antibodies Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPA's stock price target?
Not Available

IPA doesn't have any price targets made by Wall Street professionals.

Back to Top